Valuation: Merck KGaA

Capitalization 48.63B 57.08B 45.01B 42.38B 78.93B 5,309B 80.55B 528B 207B 2,549B 214B 210B 9,084B P/E ratio 2026 *
18.6x
P/E ratio 2027 * 16x
Enterprise value 55.72B 65.4B 51.56B 48.55B 90.43B 6,083B 92.28B 605B 237B 2,921B 245B 240B 10,407B EV / Sales 2026 *
2.65x
EV / Sales 2027 * 2.43x
Free-Float
29.72%
Yield 2026 *
2.13%
Yield 2027 * 2.22%
1 day+0.40%
1 week+1.87%
Current month+3.95%
1 month+0.77%
3 months-12.82%
6 months-3.66%
Current year-8.77%
1 week 107.25
Extreme 107.25
114.2
1 month 100.7
Extreme 100.7
114.2
Current year 100.7
Extreme 100.7
131.65
1 year 100.7
Extreme 100.7
131.65
3 years 100.7
Extreme 100.7
177
5 years 100.7
Extreme 100.7
231.5
10 years 74.54
Extreme 74.54
231.5
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2021
Director of Finance/CFO 55 01/07/2023
Chief Tech/Sci/R&D Officer - 01/07/2021
Director TitleAgeSince
Director/Board Member - 26/04/2019
Director/Board Member 63 01/05/2012
Director/Board Member 77 09/05/2014
Change 5d. change 1-year change 3-years change Capi.($)
+0.40%+1.87%-2.99%-35.46% 57.08B
-2.10%-1.33%+23.07%-13.25% 8.44B
+1.10%+5.16%+12.62%+84.59% 8.03B
+0.92%+4.68%-3.53%+42.34% 5.2B
-0.96%+0.11%-15.31%+72.34% 4.66B
-1.59%+0.40%+60.03%+37.61% 2.92B
+0.32%+0.16%-13.00%-37.70% 2.73B
+0.74%+4.31%+30.00%+35.83% 2.46B
+0.39%-1.33%+2.97%-15.72% 2.04B
+0.33%+1.43%+80.93%-1.77% 1.98B
Average -0.04%+1.47%+17.48%+16.88% 9.55B
Weighted average by Cap. +0.14%+1.77%+4.35%-8.79%

Financials

2026 *2027 *
Net sales 20.99B 24.64B 19.42B 18.29B 34.07B 2,291B 34.77B 228B 89.16B 1,100B 92.46B 90.5B 3,921B 22.03B 25.86B 20.39B 19.2B 35.76B 2,405B 36.49B 239B 93.6B 1,155B 97.06B 95B 4,116B
Net income 2.62B 3.07B 2.42B 2.28B 4.25B 286B 4.33B 28.4B 11.11B 137B 11.52B 11.28B 489B 3.02B 3.55B 2.8B 2.63B 4.91B 330B 5.01B 32.81B 12.84B 158B 13.31B 13.03B 565B
Net Debt 7.09B 8.32B 6.56B 6.17B 11.5B 774B 11.74B 76.93B 30.1B 371B 31.21B 30.55B 1,324B 5.02B 5.89B 4.64B 4.37B 8.15B 548B 8.31B 54.49B 21.32B 263B 22.11B 21.64B 937B
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
59,077
Date Price Change Volume
10/04/26 111.85 +0.40% 240,768
09/04/26 111.40 -1.33% 271,623
08/04/26 112.90 +5.17% 418,847
07/04/26 107.35 -2.23% 251,817
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
111.85EUR
Average target price
141.67EUR
Spread / Average Target
+26.66%

Quarterly revenue - Rate of surprise